|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
216 a.a.
|
|
|
|
|
|
|
|
|
|
|
214 a.a.
|
|
|
|
|
|
|
|
|
|
|
217 a.a.
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
|
PDB id:
|
|
|
|
| Name: |
|
Signaling protein
|
|
|
Title:
|
|
Crystal structure of the human beta2 adrenoceptor
|
|
Structure:
|
|
Beta-2 adrenergic receptor. Chain: a. Synonym: beta-2 adrenoceptor, beta-2 adrenoreceptor. Engineered: yes. Antibody for beta2 adrenoceptor, light chain. Chain: l. Antibody for beta2 adrenoceptor, heavy chain. Chain: h
|
|
Source:
|
|
Homo sapiens. Human. Organism_taxid: 9606. Gene: adrb2, adrb2r, b2ar. Mus musculus. House mouse. Organism_taxid: 10090. Organism_taxid: 10090
|
|
Resolution:
|
|
|
3.40Å
|
R-factor:
|
0.217
|
R-free:
|
0.270
|
|
|
Authors:
|
|
S.G.F.Rasmussen,H.J.Choi,D.M.Rosenbaum,T.S.Kobilka,F.S.Thian, P.C.Edwards,M.Burghammer,V.R.Ratnala,R.Sanishvili,R.F.Fischetti, G.F.Schertler,W.I.Weis,B.K.Kobilka
|
Key ref:
|
|
S.G.Rasmussen
et al.
(2007).
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
Nature,
450,
383-387.
PubMed id:
DOI:
|
|
|
Date:
|
|
|
31-Aug-07
|
Release date:
|
06-Nov-07
|
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
|
Headers
|
|
|
|
References
|
|
|
|
|
|
|
|
P07550
(ADRB2_HUMAN) -
Beta-2 adrenergic receptor from Homo sapiens
|
|
|
|
Seq:
Struc:
|
|
|
|
413 a.a.
216 a.a.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
| |
|
DOI no:
|
Nature
450:383-387
(2007)
|
|
PubMed id:
|
|
|
|
|
|
| |
|
Crystal structure of the human beta2 adrenergic G-protein-coupled receptor.
|
|
S.G.Rasmussen,
H.J.Choi,
D.M.Rosenbaum,
T.S.Kobilka,
F.S.Thian,
P.C.Edwards,
M.Burghammer,
V.R.Ratnala,
R.Sanishvili,
R.F.Fischetti,
G.F.Schertler,
W.I.Weis,
B.K.Kobilka.
|
|
|
|
|
| |
ABSTRACT
|
|
|
|
| |
|
|
Structural analysis of G-protein-coupled receptors (GPCRs) for hormones and
neurotransmitters has been hindered by their low natural abundance, inherent
structural flexibility, and instability in detergent solutions. Here we report a
structure of the human beta2 adrenoceptor (beta2AR), which was crystallized in a
lipid environment when bound to an inverse agonist and in complex with a Fab
that binds to the third intracellular loop. Diffraction data were obtained by
high-brilliance microcrystallography and the structure determined at 3.4 A/3.7 A
resolution. The cytoplasmic ends of the beta2AR transmembrane segments and the
connecting loops are well resolved, whereas the extracellular regions of the
beta2AR are not seen. The beta2AR structure differs from rhodopsin in having
weaker interactions between the cytoplasmic ends of transmembrane (TM)3 and TM6,
involving the conserved E/DRY sequences. These differences may be responsible
for the relatively high basal activity and structural instability of the
beta2AR, and contribute to the challenges in obtaining diffraction-quality
crystals of non-rhodopsin GPCRs.
|
|
|
|
|
|
| |
Selected figure(s)
|
|
|
|
| |
|
|
|
|
|
|
Figure 3.
Figure 3: Comparison of beta- [2]AR
and rhodopsin structures. a, The 
[2]AR is superimposed with the homologous structure of
rhodopsin^6. Retinal is shown in purple and the electron density
in the putative ligand-binding site is shown as a green mesh.
Structures were aligned using all seven transmembrane segments.
The right panels represent cross-sections that are rotated
90° around the horizontal axis and viewed from the
extracellular face of the receptor. b, Comparison of the [2]AR
with structures of inactive rhodopsin and light-activated
rhodopsin around the conserved E/DRY sequence in TM3. A
dashed line shows the distance between the homologous arginine
in TM3 and glutamate in TM6. To facilitate comparison of the
E/DRY regions, the structures were aligned by superimposing TM3
only.
|
|
Figure 4.
Figure 4: Side-chain interactions between Leu 272 and residues
in TM3, TM5 and intracellular loop 2. Packing interactions
are reflected in lower B-factors for these amino acids. The
average B value of residues 135, 141, 219, 222, 272 and 275 is
117 Å^2, compared to 157 Å^2 for the receptor as a
whole.
|
|
|
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nature
(2007,
450,
383-387)
copyright 2007.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
|
| |
PubMed id
|
|
Reference
|
|
|
|
|
|
A.J.Venkatakrishnan,
X.Deupi,
G.Lebon,
C.G.Tate,
G.F.Schertler,
and
M.M.Babu
(2013).
Molecular signatures of G-protein-coupled receptors.
|
| |
Nature,
494,
185-194.
|
|
|
|
|
|
|
S.H.Park,
B.B.Das,
F.Casagrande,
Y.Tian,
H.J.Nothnagel,
M.Chu,
H.Kiefer,
K.Maier,
A.A.De Angelis,
F.M.Marassi,
and
S.J.Opella
(2012).
Structure of the chemokine receptor CXCR1 in phospholipid bilayers.
|
| |
Nature,
491,
779-783.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
T.Hino,
T.Arakawa,
H.Iwanari,
T.Yurugi-Kobayashi,
C.Ikeda-Suno,
Y.Nakada-Nakura,
O.Kusano-Arai,
S.Weyand,
T.Shimamura,
N.Nomura,
A.D.Cameron,
T.Kobayashi,
T.Hamakubo,
S.Iwata,
and
T.Murata
(2012).
G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody.
|
| |
Nature,
482,
237-240.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
A.Grossfield
(2011).
Recent progress in the study of G protein-coupled receptors with molecular dynamics computer simulations.
|
| |
Biochim Biophys Acta,
1808,
1868-1878.
|
|
|
|
|
|
|
B.K.Kobilka
(2011).
Structural insights into adrenergic receptor function and pharmacology.
|
| |
Trends Pharmacol Sci,
32,
213-218.
|
|
|
|
|
|
|
D.Guidolin,
F.Ciruela,
S.Genedani,
M.Guescini,
C.Tortorella,
G.Albertin,
K.Fuxe,
and
L.F.Agnati
(2011).
Bioinformatics and mathematical modelling in the study of receptor-receptor interactions and receptor oligomerization: focus on adenosine receptors.
|
| |
Biochim Biophys Acta,
1808,
1267-1283.
|
|
|
|
|
|
|
D.van der Spoel,
E.G.Marklund,
D.S.Larsson,
and
C.Caleman
(2011).
Proteins, lipids, and water in the gas phase.
|
| |
Macromol Biosci,
11,
50-59.
|
|
|
|
|
|
|
E.K.Tiburu,
S.Tyukhtenko,
H.Zhou,
D.R.Janero,
J.Struppe,
and
A.Makriyannis
(2011).
Human cannabinoid 1 GPCR C-terminal domain interacts with bilayer phospholipids to modulate the structure of its membrane environment.
|
| |
AAPS J,
13,
92-98.
|
|
|
|
|
|
|
E.Yuriev,
M.Agostino,
and
P.A.Ramsland
(2011).
Challenges and advances in computational docking: 2009 in review.
|
| |
J Mol Recognit,
24,
149-164.
|
|
|
|
|
|
|
F.Deflorian,
and
K.A.Jacobson
(2011).
Comparison of three GPCR structural templates for modeling of the P2Y(12) nucleotide receptor.
|
| |
J Comput Aided Mol Des,
25,
329-338.
|
|
|
|
|
|
|
F.Fanelli,
and
A.Felline
(2011).
Dimerization and ligand binding affect the structure network of A(2A) adenosine receptor.
|
| |
Biochim Biophys Acta,
1808,
1256-1266.
|
|
|
|
|
|
|
F.Xu,
H.Wu,
V.Katritch,
G.W.Han,
K.A.Jacobson,
Z.G.Gao,
V.Cherezov,
and
R.C.Stevens
(2011).
Structure of an agonist-bound human A2A adenosine receptor.
|
| |
Science,
332,
322-327.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
G.Lebon,
T.Warne,
P.C.Edwards,
K.Bennett,
C.J.Langmead,
A.G.Leslie,
and
C.G.Tate
(2011).
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
|
| |
Nature,
474,
521-525.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
H.W.Choe,
J.H.Park,
Y.J.Kim,
and
O.P.Ernst
(2011).
Transmembrane signaling by GPCRs: insight from rhodopsin and opsin structures.
|
| |
Neuropharmacology,
60,
52-57.
|
|
|
|
|
|
|
H.Yabuuchi,
S.Niijima,
H.Takematsu,
T.Ida,
T.Hirokawa,
T.Hara,
T.Ogawa,
Y.Minowa,
G.Tsujimoto,
and
Y.Okuno
(2011).
Analysis of multiple compound-protein interactions reveals novel bioactive molecules.
|
| |
Mol Syst Biol,
7,
472.
|
|
|
|
|
|
|
I.Dodevski,
and
A.Plückthun
(2011).
Evolution of three human GPCRs for higher expression and stability.
|
| |
J Mol Biol,
408,
599-615.
|
|
|
|
|
|
|
J.C.Pai,
J.A.Culver,
J.E.Drury,
R.S.Motani,
R.L.Lieberman,
and
J.A.Maynard
(2011).
Conversion of scFv peptide-binding specificity for crystal chaperone development.
|
| |
Protein Eng Des Sel,
24,
419-428.
|
|
|
|
|
|
|
K.J.Gregory,
E.N.Dong,
J.Meiler,
and
P.J.Conn
(2011).
Allosteric modulation of metabotropic glutamate receptors: structural insights and therapeutic potential.
|
| |
Neuropharmacology,
60,
66-81.
|
|
|
|
|
|
|
L.M.Simpson,
I.D.Wall,
F.E.Blaney,
and
C.A.Reynolds
(2011).
Modeling GPCR active state conformations: the β(2)-adrenergic receptor.
|
| |
Proteins,
79,
1441-1457.
|
|
|
|
|
|
|
L.Zhu,
D.Frenkel,
and
P.G.Bolhuis
(2011).
Role of fluctuations in ligand binding cooperativity of membrane receptors.
|
| |
Phys Rev Lett,
106,
168103.
|
|
|
|
|
|
|
M.Ambrosio,
A.Zürn,
and
M.J.Lohse
(2011).
Sensing G protein-coupled receptor activation.
|
| |
Neuropharmacology,
60,
45-51.
|
|
|
|
|
|
|
M.E.Silva,
R.Heim,
A.Strasser,
S.Elz,
and
S.Dove
(2011).
Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor.
|
| |
J Comput Aided Mol Des,
25,
51-66.
|
|
|
|
|
|
|
M.J.Chalmers,
S.A.Busby,
B.D.Pascal,
G.M.West,
and
P.R.Griffin
(2011).
Differential hydrogen/deuterium exchange mass spectrometry analysis of protein-ligand interactions.
|
| |
Expert Rev Proteomics,
8,
43-59.
|
|
|
|
|
|
|
P.Keov,
P.M.Sexton,
and
A.Christopoulos
(2011).
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
|
| |
Neuropharmacology,
60,
24-35.
|
|
|
|
|
|
|
R.Cavicchioli
(2011).
Archaea--timeline of the third domain.
|
| |
Nat Rev Microbiol,
9,
51-61.
|
|
|
|
|
|
|
R.E.Hubbard
(2011).
Structure-based drug discovery and protein targets in the CNS.
|
| |
Neuropharmacology,
60,
7.
|
|
|
|
|
|
|
R.M.Bill,
P.J.Henderson,
S.Iwata,
E.R.Kunji,
H.Michel,
R.Neutze,
S.Newstead,
B.Poolman,
C.G.Tate,
and
H.Vogel
(2011).
Overcoming barriers to membrane protein structure determination.
|
| |
Nat Biotechnol,
29,
335-340.
|
|
|
|
|
|
|
R.Sanishvili,
D.W.Yoder,
S.B.Pothineni,
G.Rosenbaum,
S.Xu,
S.Vogt,
S.Stepanov,
O.A.Makarov,
S.Corcoran,
R.Benn,
V.Nagarajan,
J.L.Smith,
and
R.F.Fischetti
(2011).
Radiation damage in protein crystals is reduced with a micron-sized X-ray beam.
|
| |
Proc Natl Acad Sci U S A,
108,
6127-6132.
|
|
|
|
|
|
|
R.Stadel,
K.H.Ahn,
and
D.A.Kendall
(2011).
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.
|
| |
J Neurochem,
117,
1.
|
|
|
|
|
|
|
S.Bhatnagar,
S.Mishra,
and
R.Pathak
(2011).
Mining human genome for novel purinergic P2Y receptors: a sequence analysis and molecular modeling approach.
|
| |
J Recept Signal Transduct Res,
31,
75-84.
|
|
|
|
|
|
|
S.G.Rasmussen,
B.T.DeVree,
Y.Zou,
A.C.Kruse,
K.Y.Chung,
T.S.Kobilka,
F.S.Thian,
P.S.Chae,
E.Pardon,
D.Calinski,
J.M.Mathiesen,
S.T.Shah,
J.A.Lyons,
M.Caffrey,
S.H.Gellman,
J.Steyaert,
G.Skiniotis,
W.I.Weis,
R.K.Sunahara,
and
B.K.Kobilka
(2011).
Crystal structure of the β2 adrenergic receptor-Gs protein complex.
|
| |
Nature,
477,
549-555.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
S.G.Rasmussen,
H.J.Choi,
J.J.Fung,
E.Pardon,
P.Casarosa,
P.S.Chae,
B.T.Devree,
D.M.Rosenbaum,
F.S.Thian,
T.S.Kobilka,
A.Schnapp,
I.Konetzki,
R.K.Sunahara,
S.H.Gellman,
A.Pautsch,
J.Steyaert,
W.I.Weis,
and
B.K.Kobilka
(2011).
Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.
|
| |
Nature,
469,
175-180.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
S.Meini,
F.Bellucci,
C.Catalani,
P.Cucchi,
A.Giolitti,
S.Giuliani,
L.Quartara,
L.Rotondaro,
S.Zappitelli,
and
C.A.Maggi
(2011).
Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin Bâ‚‚ receptor.
|
| |
Br J Pharmacol,
162,
1202-1212.
|
|
|
|
|
|
|
S.Topiol,
M.Sabio,
and
M.Uberti
(2011).
Exploration of structure-based drug design opportunities for mGluRs.
|
| |
Neuropharmacology,
60,
93.
|
|
|
|
|
|
|
T.Warne,
R.Moukhametzianov,
J.G.Baker,
R.Nehmé,
P.C.Edwards,
A.G.Leslie,
G.F.Schertler,
and
C.G.Tate
(2011).
The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
|
| |
Nature,
469,
241-244.
|
|
|
PDB codes:
|
|
|
|
|
|
|
|
A.Gautier,
H.R.Mott,
M.J.Bostock,
J.P.Kirkpatrick,
and
D.Nietlispach
(2010).
Structure determination of the seven-helix transmembrane receptor sensory rhodopsin II by solution NMR spectroscopy.
|
| |
Nat Struct Mol Biol,
17,
768-774.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
A.Rayan
(2010).
New vistas in GPCR 3D structure prediction.
|
| |
J Mol Model,
16,
183-191.
|
|
|
|
|
|
|
A.Strasser,
and
H.J.Wittmann
(2010).
Distinct interactions between the human adrenergic beta(2) receptor and Galpha(s)--an in silico study.
|
| |
J Mol Model,
16,
1307-1318.
|
|
|
|
|
|
|
A.Strasser,
and
H.J.Wittmann
(2010).
In silico analysis of the histaprodifen induced activation pathway of the guinea-pig histamine H(1)-receptor.
|
| |
J Comput Aided Mol Des,
24,
759-769.
|
|
|
|
|
|
|
B.Holst,
R.Nygaard,
L.Valentin-Hansen,
A.Bach,
M.S.Engelstoft,
P.S.Petersen,
T.M.Frimurer,
and
T.W.Schwartz
(2010).
A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.
|
| |
J Biol Chem,
285,
3973-3985.
|
|
|
|
|
|
|
B.N.Mallick,
S.Singh,
and
A.Singh
(2010).
Mechanism of noradrenaline-induced stimulation of Na-K ATPase activity in the rat brain: implications on REM sleep deprivation-induced increase in brain excitability.
|
| |
Mol Cell Biochem,
336,
3.
|
|
|
|
|
|
|
C.Parravicini,
M.P.Abbracchio,
P.Fantucci,
and
G.Ranghino
(2010).
Forced unbinding of GPR17 ligands from wild type and R255I mutant receptor models through a computational approach.
|
| |
BMC Struct Biol,
10,
8.
|
|
|
|
|
|
|
C.Rouget,
L.Quinton,
A.Maïga,
C.Gales,
G.Masuyer,
C.Malosse,
J.Chamot-Rooke,
R.Thai,
G.Mourier,
E.De Pauw,
N.Gilles,
and
D.Servent
(2010).
Identification of a novel snake peptide toxin displaying high affinity and antagonist behaviour for the α2-adrenoceptors.
|
| |
Br J Pharmacol,
161,
1361-1374.
|
|
|
|
|
|
|
D.Dal Ben,
I.Antonini,
M.Buccioni,
C.Lambertucci,
G.Marucci,
S.Vittori,
R.Volpini,
and
G.Cristalli
(2010).
Molecular modeling studies on the human neuropeptide S receptor and its antagonists.
|
| |
ChemMedChem,
5,
371-383.
|
|
|
|
|
|
|
D.G.Cronshaw,
Y.Nie,
J.Waite,
and
Y.R.Zou
(2010).
An essential role of the cytoplasmic tail of CXCR4 in g-protein signaling and organogenesis.
|
| |
PLoS One,
5,
e15397.
|
|
|
|
|
|
|
D.N.Langelaan,
and
J.K.Rainey
(2010).
Membrane catalysis of peptide-receptor binding.
|
| |
Biochem Cell Biol,
88,
203-210.
|
|
|
|
|
|
|
E.Alvarez-Curto,
J.D.Pediani,
and
G.Milligan
(2010).
Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors.
|
| |
Anal Bioanal Chem,
398,
167-180.
|
|
|
|
|
|
|
E.J.Helmreich
(2010).
Ways and means of coping with uncertainties of the relationship of the genetic blue print to protein structure and function in the cell.
|
| |
Cell Commun Signal,
8,
26.
|
|
|
|
|
|
|
E.van der Horst,
J.E.Peironcely,
A.P.Ijzerman,
M.W.Beukers,
J.R.Lane,
H.W.van Vlijmen,
M.T.Emmerich,
Y.Okuno,
and
A.Bender
(2010).
A novel chemogenomics analysis of G protein-coupled receptors (GPCRs) and their ligands: a potential strategy for receptor de-orphanization.
|
| |
BMC Bioinformatics,
11,
316.
|
|
|
|
|
|
|
F.P.Leu,
and
M.Nandi
(2010).
GPCR somatostatin receptor extracellular loop 2 is a key ectodomain for making subtype-selective antibodies with agonist-like activities in the pancreatic neuroendocrine tumor BON cell line.
|
| |
Pancreas,
39,
1155-1166.
|
|
|
|
|
|
|
I.Muller,
V.Sarramégna,
A.Milon,
and
F.J.Talmont
(2010).
The N-terminal end truncated mu-opioid receptor: from expression to circular dichroism analysis.
|
| |
Appl Biochem Biotechnol,
160,
2175-2186.
|
|
|
|
|
|
|
J.A.Goncalves,
S.Ahuja,
S.Erfani,
M.Eilers,
and
S.O.Smith
(2010).
Structure and function of G protein-coupled receptors using NMR spectroscopy.
|
| |
Prog Nucl Magn Reson Spectrosc,
57,
159-180.
|
|
|
|
|
|
|
J.F.White,
and
R.Grisshammer
(2010).
Stability of the neurotensin receptor NTS1 free in detergent solution and immobilized to affinity resin.
|
| |
PLoS One,
5,
e12579.
|
|
|
|
|
|
|
J.G.Baker
(2010).
A full pharmacological analysis of the three turkey β-adrenoceptors and comparison with the human β-adrenoceptors.
|
| |
PLoS One,
5,
e15487.
|
|
|
|
|
|
|
J.Hu,
Y.Wang,
X.Zhang,
J.R.Lloyd,
J.H.Li,
J.Karpiak,
S.Costanzi,
and
J.Wess
(2010).
Structural basis of G protein-coupled receptor-G protein interactions.
|
| |
Nat Chem Biol,
6,
541-548.
|
|
|
|
|
|
|
J.J.Tesmer
(2010).
The quest to understand heterotrimeric G protein signaling.
|
| |
Nat Struct Mol Biol,
17,
650-652.
|
|
|
|
|
|
|
J.K.Lee,
and
R.M.Stroud
(2010).
Unlocking the eukaryotic membrane protein structural proteome.
|
| |
Curr Opin Struct Biol,
20,
464-470.
|
|
|
|
|
|
|
J.P.Slack,
A.Brockhoff,
C.Batram,
S.Menzel,
C.Sonnabend,
S.Born,
M.M.Galindo,
S.Kohl,
S.Thalmann,
L.Ostopovici-Halip,
C.T.Simons,
I.Ungureanu,
K.Duineveld,
C.G.Bologa,
M.Behrens,
S.Furrer,
T.I.Oprea,
and
W.Meyerhof
(2010).
Modulation of bitter taste perception by a small molecule hTAS2R antagonist.
|
| |
Curr Biol,
20,
1104-1109.
|
|
|
|
|
|
|
J.P.Vilardaga
(2010).
Theme and variations on kinetics of GPCR activation/deactivation.
|
| |
J Recept Signal Transduct Res,
30,
304-312.
|
|
|
|
|
|
|
J.R.Baker,
J.D.Hothersall,
R.J.Fitzmaurice,
M.Tucknott,
A.Vinter,
A.Tinker,
and
S.Caddick
(2010).
An efficient asymmetric synthesis of the potent beta-blocker ICI-118,551 allows the determination of enantiomer dependency on biological activity.
|
| |
Chem Commun (Camb),
46,
3953-3954.
|
|
|
|
|
|
|
J.Y.Shim
(2010).
Understanding functional residues of the cannabinoid CB1.
|
| |
Curr Top Med Chem,
10,
779-798.
|
|
|
|
|
|
|
K.Fuxe,
D.Marcellino,
D.O.Borroto-Escuela,
M.Frankowska,
L.Ferraro,
D.Guidolin,
F.Ciruela,
and
L.F.Agnati
(2010).
The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions.
|
| |
J Recept Signal Transduct Res,
30,
272-283.
|
|
|
|
|
|
|
K.H.Ahn,
A.Nishiyama,
D.F.Mierke,
and
D.A.Kendall
(2010).
Hydrophobic residues in helix 8 of cannabinoid receptor 1 are critical for structural and functional properties.
|
| |
Biochemistry,
49,
502-511.
|
|
|
|
|
|
|
K.J.Leck,
S.Zhang,
and
C.A.Hauser
(2010).
Study of bioengineered zebra fish olfactory receptor 131-2: receptor purification and secondary structure analysis.
|
| |
PLoS One,
5,
e15027.
|
|
|
|
|
|
|
K.J.Perry,
V.R.Johnson,
E.L.Malloch,
L.Fukui,
J.Wever,
A.G.Thomas,
P.W.Hamilton,
and
J.J.Henry
(2010).
The G-protein-coupled receptor, GPR84, is important for eye development in Xenopus laevis.
|
| |
Dev Dyn,
239,
3024-3037.
|
|
|
|
|
|
|
K.McLuskey,
A.W.Roszak,
Y.Zhu,
and
N.W.Isaacs
(2010).
Crystal structures of all-alpha type membrane proteins.
|
| |
Eur Biophys J,
39,
723-755.
|
|
|
|
|
|
|
K.Sakai,
Y.Imamoto,
T.Yamashita,
and
Y.Shichida
(2010).
Functional analysis of the second extracellular loop of rhodopsin by characterizing split variants.
|
| |
Photochem Photobiol Sci,
9,
1490-1497.
|
|
|
|
|
|
|
L.E.Petrovskaya,
A.A.Shulga,
O.V.Bocharova,
Y.S.Ermolyuk,
E.A.Kryukova,
V.V.Chupin,
M.J.Blommers,
A.S.Arseniev,
and
M.P.Kirpichnikov
(2010).
Expression of G-protein coupled receptors in Escherichia coli for structural studies.
|
| |
Biochemistry (Mosc),
75,
881-891.
|
|
|
|
|
|
|
L.López,
J.Selent,
R.Ortega,
C.F.Masaguer,
E.Domínguez,
F.Areias,
J.Brea,
M.I.Loza,
F.Sanz,
and
M.Pastor
(2010).
Synthesis, 3D-QSAR, and structural modeling of benzolactam derivatives with binding affinity for the D(2) and D(3) receptors.
|
| |
ChemMedChem,
5,
1300-1317.
|
|
|
|
|
|
|
M.A.Khan,
and
A.D.Conigrave
(2010).
Mechanisms of multimodal sensing by extracellular Ca(2+)-sensing receptors: a domain-based survey of requirements for binding and signalling.
|
| |
Br J Pharmacol,
159,
1039-1050.
|
|
|
|
|
|
|
M.A.Soriano-Ursúa,
J.G.Trujillo-Ferrara,
J.Alvarez-Cedillo,
and
J.Correa-Basurto
(2010).
Docking studies on a refined human beta(2) adrenoceptor model yield theoretical affinity values in function with experimental values for R-ligands, but not for S-antagonists.
|
| |
J Mol Model,
16,
401-409.
|
|
|
|
|
|
|
M.Ambrosio,
F.Fanelli,
S.Brocchetti,
F.Raimondi,
M.Mauri,
G.E.Rovati,
and
V.Capra
(2010).
Superactive mutants of thromboxane prostanoid receptor: functional and computational analysis of an active form alternative to constitutively active mutants.
|
| |
Cell Mol Life Sci,
67,
2979-2989.
|
|
|
|
|
|
|
M.Arakawa,
N.Yanamala,
J.Upadhyaya,
A.Halayko,
J.Klein-Seetharaman,
and
P.Chelikani
(2010).
The importance of valine 114 in ligand binding in beta(2)-adrenergic receptor.
|
| |
Protein Sci,
19,
85-93.
|
|
|
|
|
|
|
M.Backovic,
D.X.Johansson,
B.G.Klupp,
T.C.Mettenleiter,
M.A.Persson,
and
F.A.Rey
(2010).
Efficient method for production of high yields of Fab fragments in Drosophila S2 cells.
|
| |
Protein Eng Des Sel,
23,
169-174.
|
|
|
|
|
|
|
M.Baker
(2010).
Making membrane proteins for structures: a trillion tiny tweaks.
|
| |
Nat Methods,
7,
429-434.
|
|
|
|
|
|
|
M.Baker
(2010).
Structural biology: The gatekeepers revealed.
|
| |
Nature,
465,
823-826.
|
|
|
|
|
|
|
M.Bucci,
C.Goodman,
and
T.L.Sheppard
(2010).
A decade of chemical biology.
|
| |
Nat Chem Biol,
6,
847-854.
|
|
|
|
|
|
|
M.Congreve,
and
F.Marshall
(2010).
The impact of GPCR structures on pharmacology and structure-based drug design.
|
| |
Br J Pharmacol,
159,
986-996.
|
|
|
|
|
|
|
M.Filizola
(2010).
Increasingly accurate dynamic molecular models of G-protein coupled receptor oligomers: Panacea or Pandora's box for novel drug discovery?
|
| |
Life Sci,
86,
590-597.
|
|
|
|
|
|
|
M.M.Rosenkilde,
T.Benned-Jensen,
T.M.Frimurer,
and
T.W.Schwartz
(2010).
The minor binding pocket: a major player in 7TM receptor activation.
|
| |
Trends Pharmacol Sci,
31,
567-574.
|
|
|
|
|
|
|
M.Miyano,
H.Ago,
H.Saino,
T.Hori,
and
K.Ida
(2010).
Internally bridging water molecule in transmembrane alpha-helical kink.
|
| |
Curr Opin Struct Biol,
20,
456-463.
|
|
|
|
|
|
|
M.P.Bokoch,
Y.Zou,
S.G.Rasmussen,
C.W.Liu,
R.Nygaard,
D.M.Rosenbaum,
J.J.Fung,
H.J.Choi,
F.S.Thian,
T.S.Kobilka,
J.D.Puglisi,
W.I.Weis,
L.Pardo,
R.S.Prosser,
L.Mueller,
and
B.K.Kobilka
(2010).
Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor.
|
| |
Nature,
463,
108-112.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
R.Guan,
X.Wu,
X.Feng,
M.Zhang,
T.E.Hébert,
and
D.L.Segaloff
(2010).
Structural determinants underlying constitutive dimerization of unoccupied human follitropin receptors.
|
| |
Cell Signal,
22,
247-256.
|
|
|
|
|
|
|
R.Nehmé,
and
I.Mus-Veteau
(2010).
Proteins of the Hedgehog signaling pathway as therapeutic targets against cancer.
|
| |
Expert Rev Proteomics,
7,
601-612.
|
|
|
|
|
|
|
R.O.Dror,
M.Ã.˜.Jensen,
D.W.Borhani,
and
D.E.Shaw
(2010).
Exploring atomic resolution physiology on a femtosecond to millisecond timescale using molecular dynamics simulations.
|
| |
J Gen Physiol,
135,
555-562.
|
|
|
|
|
|
|
S.J.Stahl,
N.R.Watts,
C.Rader,
M.A.DiMattia,
R.G.Mage,
I.Palmer,
J.D.Kaufman,
J.M.Grimes,
D.I.Stuart,
A.C.Steven,
and
P.T.Wingfield
(2010).
Generation and characterization of a chimeric rabbit/human Fab for co-crystallization of HIV-1 Rev.
|
| |
J Mol Biol,
397,
697-708.
|
|
|
|
|
|
|
S.Mueller,
H.Jaeschke,
R.Günther,
and
R.Paschke
(2010).
The hinge region: an important receptor component for GPHR function.
|
| |
Trends Endocrinol Metab,
21,
111-122.
|
|
|
|
|
|
|
T.Angelotti,
D.Daunt,
O.G.Shcherbakova,
B.Kobilka,
and
C.M.Hurt
(2010).
Regulation of G-protein coupled receptor traffic by an evolutionary conserved hydrophobic signal.
|
| |
Traffic,
11,
560-578.
|
|
|
|
|
|
|
T.D.Romo,
A.Grossfield,
and
M.C.Pitman
(2010).
Concerted interconversion between ionic lock substates of the beta(2) adrenergic receptor revealed by microsecond timescale molecular dynamics.
|
| |
Biophys J,
98,
76-84.
|
|
|
|
|
|
|
T.Kouyama,
and
M.Murakami
(2010).
Structural divergence and functional versatility of the rhodopsin superfamily.
|
| |
Photochem Photobiol Sci,
9,
1458-1465.
|
|
|
|
|
|
|
T.Qiu,
X.Wu,
F.Zhang,
T.L.Clemens,
M.Wan,
and
X.Cao
(2010).
TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
|
| |
Nat Cell Biol,
12,
224-234.
|
|
|
|
|
|
|
T.Sakurai,
T.Misaka,
M.Ishiguro,
K.Masuda,
T.Sugawara,
K.Ito,
T.Kobayashi,
S.Matsuo,
Y.Ishimaru,
T.Asakura,
and
K.Abe
(2010).
Characterization of the beta-D-glucopyranoside binding site of the human bitter taste receptor hTAS2R16.
|
| |
J Biol Chem,
285,
28373-28378.
|
|
|
|
|
|
|
T.Varin,
H.Gutiérrez-de-Terán,
M.Castro,
J.Brea,
F.Fabis,
F.Dauphin,
J.Aqvist,
A.Lepailleur,
P.Perez,
J.Burgueño,
J.M.Vela,
M.I.Loza,
and
J.Rodrigo
(2010).
Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.
|
| |
Br J Pharmacol,
159,
1069-1081.
|
|
|
|
|
|
|
T.Werner,
K.Sander,
Y.Tanrikulu,
T.Kottke,
E.Proschak,
H.Stark,
and
G.Schneider
(2010).
In silico characterization of ligand binding modes in the human histamine H4 receptor and their impact on receptor activation.
|
| |
Chembiochem,
11,
1850-1855.
|
|
|
|
|
|
|
V.Cherezov,
E.Abola,
and
R.C.Stevens
(2010).
Recent progress in the structure determination of GPCRs, a membrane protein family with high potential as pharmaceutical targets.
|
| |
Methods Mol Biol,
654,
141-168.
|
|
|
|
|
|
|
V.Früh,
Y.Zhou,
D.Chen,
C.Loch,
E.Ab,
Y.N.Grinkova,
H.Verheij,
S.G.Sligar,
J.H.Bushweller,
and
G.Siegal
(2010).
Application of fragment-based drug discovery to membrane proteins: identification of ligands of the integral membrane enzyme DsbB.
|
| |
Chem Biol,
17,
881-891.
|
|
|
|
|
|
|
V.P.Jaakola,
and
A.P.Ijzerman
(2010).
The crystallographic structure of the human adenosine A2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design.
|
| |
Curr Opin Struct Biol,
20,
401-414.
|
|
|
|
|
|
|
X.Biarnés,
A.Marchiori,
A.Giorgetti,
C.Lanzara,
P.Gasparini,
P.Carloni,
S.Born,
A.Brockhoff,
M.Behrens,
and
W.Meyerhof
(2010).
Insights into the binding of Phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor.
|
| |
PLoS One,
5,
e12394.
|
|
|
|
|
|
|
X.Deupi,
and
B.K.Kobilka
(2010).
Energy landscapes as a tool to integrate GPCR structure, dynamics, and function.
|
| |
Physiology (Bethesda),
25,
293-303.
|
|
|
|
|
|
|
X.Wang,
Q.Yang,
M.Li,
D.Yin,
and
Q.You
(2010).
In silico binding characteristics between human histamine H1 receptor and antagonists.
|
| |
J Mol Model,
16,
1529-1537.
|
|
|
|
|
|
|
A.A.Ivanov,
D.Barak,
and
K.A.Jacobson
(2009).
Evaluation of homology modeling of G-protein-coupled receptors in light of the A(2A) adenosine receptor crystallographic structure.
|
| |
J Med Chem,
52,
3284-3292.
|
|
|
|
|
|
|
A.Ahles,
and
S.Engelhardt
(2009).
Polymorphisms determine beta-adrenoceptor conformation: implications for cardiovascular disease and therapy.
|
| |
Trends Pharmacol Sci,
30,
188-193.
|
|
|
|
|
|
|
A.B.Tobin
(2009).
G-protein-coupled receptor structure: what can we learn?
|
| |
F1000 Biol Rep,
1,
0.
|
|
|
|
|
|
|
A.Bhattacharya
(2009).
Protein structures: Structures of desire.
|
| |
Nature,
459,
24-27.
|
|
|
|
|
|
|
A.Martin,
M.Damian,
M.Laguerre,
J.Parello,
B.Pucci,
L.Serre,
S.Mary,
J.Marie,
and
J.L.Banères
(2009).
Engineering a G protein-coupled receptor for structural studies: stabilization of the BLT1 receptor ground state.
|
| |
Protein Sci,
18,
727-734.
|
|
|
|
|
|
|
A.Neumoin,
L.S.Cohen,
B.Arshava,
S.Tantry,
J.M.Becker,
O.Zerbe,
and
F.Naider
(2009).
Structure of a double transmembrane fragment of a G-protein-coupled receptor in micelles.
|
| |
Biophys J,
96,
3187-3196.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
B.E.Lauffer,
S.Chen,
C.Melero,
T.Kortemme,
M.von Zastrow,
and
G.A.Vargas
(2009).
Engineered protein connectivity to actin mimics PDZ-dependent recycling of G protein-coupled receptors but not its regulation by Hrs.
|
| |
J Biol Chem,
284,
2448-2458.
|
|
|
|
|
|
|
C.L.Worth,
G.Kleinau,
and
G.Krause
(2009).
Comparative sequence and structural analyses of G-protein-coupled receptor crystal structures and implications for molecular models.
|
| |
PLoS One,
4,
e7011.
|
|
|
|
|
|
|
C.McKibbin,
N.A.Farmer,
P.C.Edwards,
C.Villa,
and
P.J.Booth
(2009).
Urea unfolding of opsin in phospholipid bicelles.
|
| |
Photochem Photobiol,
85,
494-500.
|
|
|
|
|
|
|
C.Parthier,
S.Reedtz-Runge,
R.Rudolph,
and
M.T.Stubbs
(2009).
Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
|
| |
Trends Biochem Sci,
34,
303-310.
|
|
|
|
|
|
|
D.E.Grigoriadis,
S.R.Hoare,
S.M.Lechner,
D.H.Slee,
and
J.A.Williams
(2009).
Drugability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels.
|
| |
Neuropsychopharmacology,
34,
106-125.
|
|
|
|
|
|
|
D.Langosch,
and
I.T.Arkin
(2009).
Interaction and conformational dynamics of membrane-spanning protein helices.
|
| |
Protein Sci,
18,
1343-1358.
|
|
|
|
|
|
|
D.M.Rosenbaum,
S.G.Rasmussen,
and
B.K.Kobilka
(2009).
The structure and function of G-protein-coupled receptors.
|
| |
Nature,
459,
356-363.
|
|
|
|
|
|
|
D.Mustafi,
and
K.Palczewski
(2009).
Topology of class A G protein-coupled receptors: insights gained from crystal structures of rhodopsins, adrenergic and adenosine receptors.
|
| |
Mol Pharmacol,
75,
1.
|
|
|
|
|
|
|
D.T.Lodowski,
and
K.Palczewski
(2009).
Chemokine receptors and other G protein-coupled receptors.
|
| |
Curr Opin HIV AIDS,
4,
88-95.
|
|
|
|
|
|
|
E.Lyman,
C.Higgs,
B.Kim,
D.Lupyan,
J.C.Shelley,
R.Farid,
and
G.A.Voth
(2009).
A role for a specific cholesterol interaction in stabilizing the Apo configuration of the human A(2A) adenosine receptor.
|
| |
Structure,
17,
1660-1668.
|
|
|
|
|
|
|
F.A.Hays,
Z.Roe-Zurz,
M.Li,
L.Kelly,
F.Gruswitz,
A.Sali,
and
R.M.Stroud
(2009).
Ratiocinative screen of eukaryotic integral membrane protein expression and solubilization for structure determination.
|
| |
J Struct Funct Genomics,
10,
9.
|
|
|
|
|
|
|
F.Cunningham,
A.Rath,
R.M.Johnson,
and
C.M.Deber
(2009).
Distinctions between Hydrophobic Helices in Globular Proteins and Transmembrane Segments as Factors in Protein Sorting.
|
| |
J Biol Chem,
284,
5395-5402.
|
|
|
|
|
|
|
F.Talmont
(2009).
Monitoring the human beta1, beta2, beta3 adrenergic receptors expression and purification in Pichia pastoris using the fluorescence properties of the enhanced green fluorescent protein.
|
| |
Biotechnol Lett,
31,
49-55.
|
|
|
|
|
|
|
G.Khelashvili,
A.Grossfield,
S.E.Feller,
M.C.Pitman,
and
H.Weinstein
(2009).
Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations.
|
| |
Proteins,
76,
403-417.
|
|
|
|
|
|
|
G.Li,
K.M.Haney,
G.E.Kellogg,
and
Y.Zhang
(2009).
Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models.
|
| |
J Chem Inf Model,
49,
120-132.
|
|
|
|
|
|
|
G.Li,
L.C.Aschenbach,
H.He,
D.E.Selley,
and
Y.Zhang
(2009).
14-O-Heterocyclic-substituted naltrexone derivatives as non-peptide mu opioid receptor selective antagonists: design, synthesis, and biological studies.
|
| |
Bioorg Med Chem Lett,
19,
1825-1829.
|
|
|
|
|
|
|
G.Li,
L.C.Aschenbach,
J.Chen,
M.P.Cassidy,
D.L.Stevens,
B.H.Gabra,
D.E.Selley,
W.L.Dewey,
R.B.Westkaemper,
and
Y.Zhang
(2009).
Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists.
|
| |
J Med Chem,
52,
1416-1427.
|
|
|
|
|
|
|
G.Skretas,
and
G.Georgiou
(2009).
Genetic analysis of G protein-coupled receptor expression in Escherichia coli: inhibitory role of DnaJ on the membrane integration of the human central cannabinoid receptor.
|
| |
Biotechnol Bioeng,
102,
357-367.
|
|
|
|
|
|
|
H.J.Atkinson,
J.H.Morris,
T.E.Ferrin,
and
P.C.Babbitt
(2009).
Using sequence similarity networks for visualization of relationships across diverse protein superfamilies.
|
| |
PLoS ONE,
4,
e4345.
|
|
|
|
|
|
|
H.J.Kim,
S.C.Howell,
W.D.Van Horn,
Y.H.Jeon,
and
C.R.Sanders
(2009).
Recent Advances in the Application of Solution NMR Spectroscopy to Multi-Span Integral Membrane Proteins.
|
| |
Prog Nucl Magn Reson Spectrosc,
55,
335-360.
|
|
|
|
|
|
|
H.Ren,
D.Yu,
B.Ge,
B.Cook,
Z.Xu,
and
S.Zhang
(2009).
High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1.
|
| |
PLoS ONE,
4,
e4509.
|
|
|
|
|
|
|
I.Domazet,
S.S.Martin,
B.J.Holleran,
M.E.Morin,
P.Lacasse,
P.Lavigne,
E.Escher,
R.Leduc,
and
G.Guillemette
(2009).
The fifth transmembrane domain of angiotensin II Type 1 receptor participates in the formation of the ligand-binding pocket and undergoes a counterclockwise rotation upon receptor activation.
|
| |
J Biol Chem,
284,
31953-31961.
|
|
|
|
|
|
|
I.G.Tikhonova,
and
S.Costanzi
(2009).
Unraveling the structure and function of G protein-coupled receptors through NMR spectroscopy.
|
| |
Curr Pharm Des,
15,
4003-4016.
|
|
|
|
|
|
|
J.A.Maynard,
N.C.Lindquist,
J.N.Sutherland,
A.Lesuffleur,
A.E.Warrington,
M.Rodriguez,
and
S.H.Oh
(2009).
Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins.
|
| |
Biotechnol J,
4,
1542-1558.
|
|
|
|
|
|
|
J.C.Mobarec,
R.Sanchez,
and
M.Filizola
(2009).
Modern homology modeling of G-protein coupled receptors: which structural template to use?
|
| |
J Med Chem,
52,
5207-5216.
|
|
|
|
|
|
|
J.Huszár,
Z.Timár,
F.Bogár,
B.Penke,
R.Kiss,
K.K.Szalai,
E.Schmidt,
A.Papp,
and
G.Keseru
(2009).
Aspartic acid scaffold in bradykinin B1 antagonists.
|
| |
J Pept Sci,
15,
423-434.
|
|
|
|
|
|
|
J.J.Fung,
X.Deupi,
L.Pardo,
X.J.Yao,
G.A.Velez-Ruiz,
B.T.Devree,
R.K.Sunahara,
and
B.K.Kobilka
(2009).
Ligand-regulated oligomerization of beta(2)-adrenoceptors in a model lipid bilayer.
|
| |
EMBO J,
28,
3315-3328.
|
|
|
|
|
|
|
J.J.Maguire,
W.A.Parker,
S.M.Foord,
T.I.Bonner,
R.R.Neubig,
and
A.P.Davenport
(2009).
International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature.
|
| |
Pharmacol Rev,
61,
1-8.
|
|
|
|
|
|
|
J.Lättig,
A.Oksche,
M.Beyermann,
W.Rosenthal,
and
G.Krause
(2009).
Structural determinants for selective recognition of peptide ligands for endothelin receptor subtypes ETA and ETB.
|
| |
J Pept Sci,
15,
479-491.
|
|
|
|
|
|
|
J.Sarmiento,
K.E.Kypreos,
G.N.Prado,
K.Suetomi,
C.Stanzel,
C.Maxwell,
D.Shumate,
M.R.Tandang-Silvas,
K.Rajarathnam,
and
J.Navarro
(2009).
Adenovirus mediated expression "in vivo" of the chemokine receptor CXCR1.
|
| |
J Struct Funct Genomics,
10,
17-23.
|
|
|
|
|
|
|
K.A.Jacobson
(2009).
Functionalized congener approach to the design of ligands for G protein-coupled receptors (GPCRs).
|
| |
Bioconjug Chem,
20,
1816-1835.
|
|
|
|
|
|
|
K.A.Reynolds,
V.Katritch,
and
R.Abagyan
(2009).
Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
|
| |
J Comput Aided Mol Des,
23,
273-288.
|
|
|
|
|
|
|
K.Bailey,
M.Bally,
W.Leifert,
J.Vörös,
and
T.McMurchie
(2009).
G-protein coupled receptor array technologies: site directed immobilisation of liposomes containing the H1-histamine or M2-muscarinic receptors.
|
| |
Proteomics,
9,
2052-2063.
|
|
|
|
|
|
|
K.Conrath,
A.S.Pereira,
C.E.Martins,
C.G.Timóteo,
P.Tavares,
S.Spinelli,
J.Kinne,
C.Flaudrops,
C.Cambillau,
S.Muyldermans,
I.Moura,
J.J.Moura,
M.Tegoni,
and
A.Desmyter
(2009).
Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase.
|
| |
Protein Sci,
18,
619-628.
|
|
|
|
|
|
|
K.H.Ahn,
A.C.Bertalovitz,
D.F.Mierke,
and
D.A.Kendall
(2009).
Dual role of the second extracellular loop of the cannabinoid receptor 1: ligand binding and receptor localization.
|
| |
Mol Pharmacol,
76,
833-842.
|
|
|
|
|
|
|
K.H.Ahn,
M.Pellegrini,
N.Tsomaia,
A.K.Yatawara,
D.A.Kendall,
and
D.F.Mierke
(2009).
Structural analysis of the human cannabinoid receptor one carboxyl-terminus identifies two amphipathic helices.
|
| |
Biopolymers,
91,
565-573.
|
|
|
|
|
|
|
K.P.Hofmann,
P.Scheerer,
P.W.Hildebrand,
H.W.Choe,
J.H.Park,
M.Heck,
and
O.P.Ernst
(2009).
A G protein-coupled receptor at work: the rhodopsin model.
|
| |
Trends Biochem Sci,
34,
540-552.
|
|
|
|
|
|
|
L.C.Purington,
I.D.Pogozheva,
J.R.Traynor,
and
H.I.Mosberg
(2009).
Pentapeptides displaying mu opioid receptor agonist and delta opioid receptor partial agonist/antagonist properties.
|
| |
J Med Chem,
52,
7724-7731.
|
|
|
|
|
|
|
L.Wang,
B.Martin,
R.Brenneman,
L.M.Luttrell,
and
S.Maudsley
(2009).
Allosteric modulators of g protein-coupled receptors: future therapeutics for complex physiological disorders.
|
| |
J Pharmacol Exp Ther,
331,
340-348.
|
|
|
|
|
|
|
M.A.Hanson,
and
R.C.Stevens
(2009).
Discovery of new GPCR biology: one receptor structure at a time.
|
| |
Structure,
17,
8.
|
|
|
|
|
|
|
M.A.Soriano-Ursúa,
J.G.Trujillo-Ferrara,
and
J.Correa-Basurto
(2009).
Homology modeling and flex-ligand docking studies on the guinea pig beta(2) adrenoceptor: structural and experimental similarities/ differences with the human beta(2).
|
| |
J Mol Model,
15,
1203-1211.
|
|
|
|
|
|
|
M.Cases,
and
J.Mestres
(2009).
A chemogenomic approach to drug discovery: focus on cardiovascular diseases.
|
| |
Drug Discov Today,
14,
479-485.
|
|
|
|
|
|
|
M.F.Brown,
K.Martínez-Mayorga,
K.Nakanishi,
G.F.Salgado,
and
A.V.Struts
(2009).
Retinal Conformation and Dynamics in Activation of Rhodopsin Illuminated by Solid-state H NMR Spectroscopy.
|
| |
Photochem Photobiol,
85,
442-453.
|
|
|
|
|
|
|
M.Freigassner,
H.Pichler,
and
A.Glieder
(2009).
wTuning microbial hosts for membrane protein production.
|
| |
Microb Cell Fact,
8,
69.
|
|
|
|
|
|
|
M.J.Serrano-Vega,
and
C.G.Tate
(2009).
Transferability of thermostabilizing mutations between beta-adrenergic receptors.
|
| |
Mol Membr Biol,
26,
385-396.
|
|
|
|
|
|
|
M.Li,
F.A.Hays,
Z.Roe-Zurz,
L.Vuong,
L.Kelly,
C.M.Ho,
R.M.Robbins,
U.Pieper,
J.D.O'Connell,
L.J.Miercke,
K.M.Giacomini,
A.Sali,
and
R.M.Stroud
(2009).
Selecting optimum eukaryotic integral membrane proteins for structure determination by rapid expression and solubilization screening.
|
| |
J Mol Biol,
385,
820-830.
|
|
|
|
|
|
|
M.M.Torrice,
K.S.Bower,
H.A.Lester,
and
D.A.Dougherty
(2009).
Probing the role of the cation-pi interaction in the binding sites of GPCRs using unnatural amino acids.
|
| |
Proc Natl Acad Sci U S A,
106,
11919-11924.
|
|
|
|
|
|
|
M.N.Davies,
J.Bayry,
E.Z.Tchilian,
J.Vani,
M.S.Shaila,
E.K.Forbes,
S.J.Draper,
P.C.Beverley,
D.F.Tough,
and
D.R.Flower
(2009).
Toward the discovery of vaccine adjuvants: coupling in silico screening and in vitro analysis of antagonist binding to human and mouse CCR4 receptors.
|
| |
PLoS One,
4,
e8084.
|
|
|
|
|
|
|
N.G.Abdulaev,
X.Mao,
E.Ramon,
T.Ngo,
J.Mysliwy,
J.P.Marino,
and
K.D.Ridge
(2009).
Designing Point Mutants to Detect Structural Coupling in a Heterotrimeric G Protein alpha-subunit by NMR Spectroscopy.
|
| |
Photochem Photobiol,
85,
431-436.
|
|
|
|
|
|
|
N.Nagamine,
T.Shirakawa,
Y.Minato,
K.Torii,
H.Kobayashi,
M.Imoto,
and
Y.Sakakibara
(2009).
Integrating statistical predictions and experimental verifications for enhancing protein-chemical interaction predictions in virtual screening.
|
| |
PLoS Comput Biol,
5,
e1000397.
|
|
|
|
|
|
|
O.Yuzlenko,
and
K.Kieć-Kononowicz
(2009).
Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
|
| |
J Comput Chem,
30,
14-32.
|
|
|
|
|
|
|
P.J.Booth,
and
P.Curnow
(2009).
Folding scene investigation: membrane proteins.
|
| |
Curr Opin Struct Biol,
19,
8.
|
|
|
|
|
|
|
P.Milovnik,
D.Ferrari,
C.A.Sarkar,
and
A.Plückthun
(2009).
Selection and characterization of DARPins specific for the neurotensin receptor 1.
|
| |
Protein Eng Des Sel,
22,
357-366.
|
|
|
|
|
|
|
P.Scheerer,
M.Heck,
A.Goede,
J.H.Park,
H.W.Choe,
O.P.Ernst,
K.P.Hofmann,
and
P.W.Hildebrand
(2009).
Structural and kinetic modeling of an activating helix switch in the rhodopsin-transducin interface.
|
| |
Proc Natl Acad Sci U S A,
106,
10660-10665.
|
|
|
|
|
|
|
P.Wellendorph,
and
H.Bräuner-Osborne
(2009).
Molecular basis for amino acid sensing by family C G-protein-coupled receptors.
|
| |
Br J Pharmacol,
156,
869-884.
|
|
|
|
|
|
|
R.A.Bauer,
S.Günther,
D.Jansen,
C.Heeger,
P.F.Thaben,
and
R.Preissner
(2009).
SuperSite: dictionary of metabolite and drug binding sites in proteins.
|
| |
Nucleic Acids Res,
37,
D195-D200.
|
|
|
|
|
|
|
R.F.Fischetti,
S.Xu,
D.W.Yoder,
M.Becker,
V.Nagarajan,
R.Sanishvili,
M.C.Hilgart,
S.Stepanov,
O.Makarov,
and
J.L.Smith
(2009).
Mini-beam collimator enables microcrystallography experiments on standard beamlines.
|
| |
J Synchrotron Radiat,
16,
217-225.
|
|
|
|
|
|
|
R.Franco
(2009).
Neurotransmitter receptor heteromers in neurodegenerative diseases and neural plasticity.
|
| |
J Neural Transm,
116,
983-987.
|
|
|
|
|
|
|
R.Heilker,
M.Wolff,
C.S.Tautermann,
and
M.Bieler
(2009).
G-protein-coupled receptor-focused drug discovery using a target class platform approach.
|
| |
Drug Discov Today,
14,
231-240.
|
|
|
|
|
|
|
R.L.Rich,
A.R.Miles,
B.K.Gale,
and
D.G.Myszka
(2009).
Detergent screening of a G-protein-coupled receptor using serial and array biosensor technologies.
|
| |
Anal Biochem,
386,
98.
|
|
|
|
|
|
|
R.Nygaard,
T.M.Frimurer,
B.Holst,
M.M.Rosenkilde,
and
T.W.Schwartz
(2009).
Ligand binding and micro-switches in 7TM receptor structures.
|
| |
Trends Pharmacol Sci,
30,
249-259.
|
|
|
|
|
|
|
R.O.Dror,
D.H.Arlow,
D.W.Borhani,
M.Ã.˜.Jensen,
S.Piana,
and
D.E.Shaw
(2009).
Identification of two distinct inactive conformations of the beta2-adrenergic receptor reconciles structural and biochemical observations.
|
| |
Proc Natl Acad Sci U S A,
106,
4689-4694.
|
|
|
|
|
|
|
R.T.Strachan,
D.J.Sheffler,
B.Willard,
M.Kinter,
J.G.Kiselar,
and
B.L.Roth
(2009).
Ribosomal S6 Kinase 2 Directly Phosphorylates the 5-Hydroxytryptamine 2A (5-HT2A) Serotonin Receptor, Thereby Modulating 5-HT2A Signaling.
|
| |
J Biol Chem,
284,
5557-5573.
|
|
|
|
|
|
|
S.Ananthan,
W.Zhang,
and
J.V.Hobrath
(2009).
Recent advances in structure-based virtual screening of G-protein coupled receptors.
|
| |
AAPS J,
11,
178-185.
|
|
|
|
|
|
|
S.Costanzi,
I.G.Tikhonova,
T.K.Harden,
and
K.A.Jacobson
(2009).
Ligand and structure-based methodologies for the prediction of the activity of G protein-coupled receptor ligands.
|
| |
J Comput Aided Mol Des,
23,
747-754.
|
|
|
|
|
|
|
S.Costanzi,
J.Siegel,
I.G.Tikhonova,
and
K.A.Jacobson
(2009).
Rhodopsin and the others: a historical perspective on structural studies of G protein-coupled receptors.
|
| |
Curr Pharm Des,
15,
3994-4002.
|
|
|
|
|
|
|
S.England,
and
M.J.de Groot
(2009).
Subtype-selective targeting of voltage-gated sodium channels.
|
| |
Br J Pharmacol,
158,
1413-1425.
|
|
|
|
|
|
|
S.F.Marino
(2009).
High-level production and characterization of a G-protein coupled receptor signaling complex.
|
| |
FEBS J,
276,
4515-4528.
|
|
|
|
|
|
|
S.H.White
(2009).
Biophysical dissection of membrane proteins.
|
| |
Nature,
459,
344-346.
|
|
|
|
|
|
|
S.J.Allen,
S.Ribeiro,
R.Horuk,
and
T.M.Handel
(2009).
Expression, purification and in vitro functional reconstitution of the chemokine receptor CCR1.
|
| |
Protein Expr Purif,
66,
73-81.
|
|
|
|
|
|
|
S.J.Cho,
N.H.Jensen,
T.Kurome,
S.Kadari,
M.L.Manzano,
J.E.Malberg,
B.Caldarone,
B.L.Roth,
and
A.P.Kozikowski
(2009).
Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action.
|
| |
J Med Chem,
52,
1885-1902.
|
|
|
|
|
|
|
S.Koide
(2009).
Engineering of recombinant crystallization chaperones.
|
| |
Curr Opin Struct Biol,
19,
449-457.
|
|
|
|
|
|
|
S.N.Fatakia,
S.Costanzi,
and
C.C.Chow
(2009).
Computing highly correlated positions using mutual information and graph theory for G protein-coupled receptors.
|
| |
PLoS ONE,
4,
e4681.
|
|
|
|
|
|
|
S.Neumann,
W.Huang,
S.Titus,
G.Krause,
G.Kleinau,
A.T.Alberobello,
W.Zheng,
N.T.Southall,
J.Inglese,
C.P.Austin,
F.S.Celi,
O.Gavrilova,
C.J.Thomas,
B.M.Raaka,
and
M.C.Gershengorn
(2009).
Small-molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice.
|
| |
Proc Natl Acad Sci U S A,
106,
12471-12476.
|
|
|
|
|
|
|
S.Raunser,
and
T.Walz
(2009).
Electron crystallography as a technique to study the structure on membrane proteins in a lipidic environment.
|
| |
Annu Rev Biophys,
38,
89.
|
|
|
|
|
|
|
T.E.Angel,
M.R.Chance,
and
K.Palczewski
(2009).
Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors.
|
| |
Proc Natl Acad Sci U S A,
106,
8555-8560.
|
|
|
|
|
|
|
T.E.Angel,
S.Gupta,
B.Jastrzebska,
K.Palczewski,
and
M.R.Chance
(2009).
Structural waters define a functional channel mediating activation of the GPCR, rhodopsin.
|
| |
Proc Natl Acad Sci U S A,
106,
14367-14372.
|
|
|
|
|
|
|
T.M.Blois,
and
J.U.Bowie
(2009).
G-protein-coupled receptor structures were not built in a day.
|
| |
Protein Sci,
18,
1335-1342.
|
|
|
|
|
|
|
T.Schwede,
A.Sali,
B.Honig,
M.Levitt,
H.M.Berman,
D.Jones,
S.E.Brenner,
S.K.Burley,
R.Das,
N.V.Dokholyan,
R.L.Dunbrack,
K.Fidelis,
A.Fiser,
A.Godzik,
Y.J.Huang,
C.Humblet,
M.P.Jacobson,
A.Joachimiak,
S.R.Krystek,
T.Kortemme,
A.Kryshtafovych,
G.T.Montelione,
J.Moult,
D.Murray,
R.Sanchez,
T.R.Sosnick,
D.M.Standley,
T.Stouch,
S.Vajda,
M.Vasquez,
J.D.Westbrook,
and
I.A.Wilson
(2009).
Outcome of a workshop on applications of protein models in biomedical research.
|
| |
Structure,
17,
151-159.
|
|
|
|
|
|
|
T.Wang,
and
Y.Duan
(2009).
Ligand entry and exit pathways in the beta2-adrenergic receptor.
|
| |
J Mol Biol,
392,
1102-1115.
|
|
|
|
|
|
|
V.Cherezov,
M.A.Hanson,
M.T.Griffith,
M.C.Hilgart,
R.Sanishvili,
V.Nagarajan,
S.Stepanov,
R.F.Fischetti,
P.Kuhn,
and
R.C.Stevens
(2009).
Rastering strategy for screening and centring of microcrystal samples of human membrane proteins with a sub-10 microm size X-ray synchrotron beam.
|
| |
J R Soc Interface,
6,
S587-S597.
|
|
|
|
|
|
|
W.Nemoto,
K.Fukui,
and
H.Toh
(2009).
GRIP: a server for predicting interfaces for GPCR oligomerization.
|
| |
J Recept Signal Transduct Res,
29,
312-317.
|
|
|
|
|
|
|
X.J.Yao,
G.Vélez Ruiz,
M.R.Whorton,
S.G.Rasmussen,
B.T.DeVree,
X.Deupi,
R.K.Sunahara,
and
B.Kobilka
(2009).
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex.
|
| |
Proc Natl Acad Sci U S A,
106,
9501-9506.
|
|
|
|
|
|
|
Y.Bromberg,
J.Overton,
C.Vaisse,
R.L.Leibel,
and
B.Rost
(2009).
In silico mutagenesis: a case study of the melanocortin 4 receptor.
|
| |
FASEB J,
23,
3059-3069.
|
|
|
|
|
|
|
Y.Shibata,
J.F.White,
M.J.Serrano-Vega,
F.Magnani,
A.L.Aloia,
R.Grisshammer,
and
C.G.Tate
(2009).
Thermostabilization of the neurotensin receptor NTS1.
|
| |
J Mol Biol,
390,
262-277.
|
|
|
|
|
|
|
Y.Tanrikulu,
E.Proschak,
T.Werner,
T.Geppert,
N.Todoroff,
A.Klenner,
T.Kottke,
K.Sander,
E.Schneider,
R.Seifert,
H.Stark,
T.Clark,
and
G.Schneider
(2009).
Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
|
| |
ChemMedChem,
4,
820-827.
|
|
|
|
|
|
|
Z.Naor
(2009).
Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor.
|
| |
Front Neuroendocrinol,
30,
10-29.
|
|
|
|
|
|
|
A.B.Tobin
(2008).
G-protein-coupled receptor phosphorylation: where, when and by whom.
|
| |
Br J Pharmacol,
153,
S167-S176.
|
|
|
|
|
|
|
A.Chillar,
J.Wu,
S.P.So,
and
K.H.Ruan
(2008).
Involvement of non-conserved residues important for PGE2 binding to the constrained EP3 eLP2 using NMR and site-directed mutagenesis.
|
| |
FEBS Lett,
582,
2863-2868.
|
|
|
|
|
|
|
A.J.Link,
G.Skretas,
E.M.Strauch,
N.S.Chari,
and
G.Georgiou
(2008).
Efficient production of membrane-integrated and detergent-soluble G protein-coupled receptors in Escherichia coli.
|
| |
Protein Sci,
17,
1857-1863.
|
|
|
|
|
|
|
A.Kato,
S.Katada,
and
K.Touhara
(2008).
Amino acids involved in conformational dynamics and G protein coupling of an odorant receptor: targeting gain-of-function mutation.
|
| |
J Neurochem,
107,
1261-1270.
|
|
|
|
|
|
|
A.L.Parrill
(2008).
Crystal structures of a second g protein-coupled receptor: triumphs and implications.
|
| |
ChemMedChem,
3,
1021-1023.
|
|
|
|
|
|
|
A.L.Parrill
(2008).
Lysophospholipid interactions with protein targets.
|
| |
Biochim Biophys Acta,
1781,
540-546.
|
|
|
|
|
|
|
A.Terakita,
H.Tsukamoto,
M.Koyanagi,
M.Sugahara,
T.Yamashita,
and
Y.Shichida
(2008).
Expression and comparative characterization of Gq-coupled invertebrate visual pigments and melanopsin.
|
| |
J Neurochem,
105,
883-890.
|
|
|
|
|
|
|
B.Isin,
K.Schulten,
E.Tajkhorshid,
and
I.Bahar
(2008).
Mechanism of signal propagation upon retinal isomerization: insights from molecular dynamics simulations of rhodopsin restrained by normal modes.
|
| |
Biophys J,
95,
789-803.
|
|
|
|
|
|
|
B.J.Arey
(2008).
Allosteric modulators of glycoprotein hormone receptors: discovery and therapeutic potential.
|
| |
Endocrine,
34,
1.
|
|
|
|
|
|
|
B.L.Cook,
K.E.Ernberg,
H.Chung,
and
S.Zhang
(2008).
Study of a synthetic human olfactory receptor 17-4: expression and purification from an inducible mammalian cell line.
|
| |
PLoS ONE,
3,
e2920.
|
|
|
|
|
|
|
B.Rees Smith,
J.Sanders,
and
J.Furmaniak
(2008).
Implications of new monoclonal antibodies and the crystal structure of the TSH receptor for the treatment and management of thyroid diseases.
|
| |
Biomark Med,
2,
567-576.
|
|
|
|
|
|
|
C.A.Sarkar,
I.Dodevski,
M.Kenig,
S.Dudli,
A.Mohr,
E.Hermans,
and
A.Plückthun
(2008).
Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity.
|
| |
Proc Natl Acad Sci U S A,
105,
14808-14813.
|
|
|
|
|
|
|
C.J.Thomas,
G.G.Tall,
A.Adhikari,
and
S.R.Sprang
(2008).
Ric-8A Catalyzes Guanine Nucleotide Exchange on G{alpha}i1 Bound to the GPR/GoLoco Exchange Inhibitor AGS3.
|
| |
J Biol Chem,
283,
23150-23160.
|
|
|
|
|
|
|
C.M.Taylor,
Y.Barda,
O.G.Kisselev,
and
G.R.Marshall
(2008).
Modulating G-protein coupled receptor/G-protein signal transduction by small molecules suggested by virtual screening.
|
| |
J Med Chem,
51,
5297-5303.
|
|
|
|
|
|
|
C.Pastori,
A.Clivio,
L.Diomede,
R.Consonni,
G.M.De Mori,
R.Longhi,
G.Colombo,
and
L.Lopalco
(2008).
Two amino acid substitutions within the first external loop of CCR5 induce human immunodeficiency virus-blocking antibodies in mice and chickens.
|
| |
J Virol,
82,
4125-4134.
|
|
|
|
|
|
|
C.V.McCulloch,
V.Morrow,
S.Milasta,
I.Comerford,
G.Milligan,
G.J.Graham,
N.W.Isaacs,
and
R.J.Nibbs
(2008).
Multiple roles for the C-terminal tail of the chemokine scavenger D6.
|
| |
J Biol Chem,
283,
7972-7982.
|
|
|
|
|
|
|
C.Xue,
Y.P.Hsueh,
and
J.Heitman
(2008).
Magnificent seven: roles of G protein-coupled receptors in extracellular sensing in fungi.
|
| |
FEMS Microbiol Rev,
32,
1010-1032.
|
|
|
|
|
|
|
D.S.Han,
S.X.Wang,
and
H.Weinstein
(2008).
Active state-like conformational elements in the beta2-AR and a photoactivated intermediate of rhodopsin identified by dynamic properties of GPCRs.
|
| |
Biochemistry,
47,
7317-7321.
|
|
|
|
|
|
|
D.Thévenin,
and
T.Lazarova
(2008).
Stable interactions between the transmembrane domains of the adenosine A2A receptor.
|
| |
Protein Sci,
17,
1188-1199.
|
|
|
|
|
|
|
E.Gregori-Puigjané,
and
J.Mestres
(2008).
Coverage and bias in chemical library design.
|
| |
Curr Opin Chem Biol,
12,
359-365.
|
|
|
|
|
|
|
E.P.Carpenter,
K.Beis,
A.D.Cameron,
and
S.Iwata
(2008).
Overcoming the challenges of membrane protein crystallography.
|
| |
Curr Opin Struct Biol,
18,
581-586.
|
|
|
|
|
|
|
E.S.Tan,
E.S.Groban,
M.P.Jacobson,
and
T.S.Scanlan
(2008).
Toward deciphering the code to aminergic G protein-coupled receptor drug design.
|
| |
Chem Biol,
15,
343-353.
|
|
|
|
|
|
|
F.Magnani,
Y.Shibata,
M.J.Serrano-Vega,
and
C.G.Tate
(2008).
Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor.
|
| |
Proc Natl Acad Sci U S A,
105,
10744-10749.
|
|
|
|
|
|
|
G.Kleinau,
H.Jaeschke,
S.Mueller,
B.M.Raaka,
S.Neumann,
R.Paschke,
and
G.Krause
(2008).
Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor.
|
| |
FASEB J,
22,
2798-2808.
|
|
|
|
|
|
|
G.Skretas,
and
G.Georgiou
(2008).
Engineering G protein-coupled receptor expression in bacteria.
|
| |
Proc Natl Acad Sci U S A,
105,
14747-14748.
|
|
|
|
|
|
|
G.Swaminath
(2008).
Fatty acid binding receptors and their physiological role in type 2 diabetes.
|
| |
Arch Pharm (Weinheim),
341,
753-761.
|
|
|
|
|
|
|
I.Muller,
V.Sarramégna,
M.Renault,
V.Lafaquière,
S.Sebai,
A.Milon,
and
F.Talmont
(2008).
The full-length mu-opioid receptor: a conformational study by circular dichroism in trifluoroethanol and membrane-mimetic environments.
|
| |
J Membr Biol,
223,
49-57.
|
|
|
|
|
|
|
J.C.Mobarec,
and
M.Filizola
(2008).
Advances in the Development and Application of Computational Methodologies for Structural Modeling of G-Protein Coupled Receptors.
|
| |
Expert Opin Drug Discov,
3,
343-355.
|
|
|
|
|
|
|
J.Chen,
G.T.Collins,
J.Zhang,
C.Y.Yang,
B.Levant,
J.Woods,
and
S.Wang
(2008).
Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.
|
| |
J Med Chem,
51,
5905-5908.
|
|
|
|
|
|
|
J.H.Park,
P.Scheerer,
K.P.Hofmann,
H.W.Choe,
and
O.P.Ernst
(2008).
Crystal structure of the ligand-free G-protein-coupled receptor opsin.
|
| |
Nature,
454,
183-187.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
J.P.Changeux,
and
A.Taly
(2008).
Nicotinic receptors, allosteric proteins and medicine.
|
| |
Trends Mol Med,
14,
93.
|
|
|
|
|
|
|
J.Wang,
and
M.Norcross
(2008).
Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy.
|
| |
Drug Discov Today,
13,
625-632.
|
|
|
|
|
|
|
J.Wess,
S.J.Han,
S.K.Kim,
K.A.Jacobson,
and
J.H.Li
(2008).
Conformational changes involved in G-protein-coupled-receptor activation.
|
| |
Trends Pharmacol Sci,
29,
616-625.
|
|
|
|
|
|
|
K.H.Ruan,
C.Wijaya,
V.Cervantes,
and
J.Wu
(2008).
Characterization of the prostaglandin H2 mimic: binding to the purified human thromboxane A2 receptor in solution.
|
| |
Arch Biochem Biophys,
477,
396-403.
|
|
|
|
|
|
|
K.M.Wannemacher,
A.Terskiy,
S.Bian,
P.N.Yadav,
H.Li,
and
R.D.Howells
(2008).
Purification and mass spectrometric analysis of the kappa opioid receptor.
|
| |
Brain Res,
1230,
13-26.
|
|
|
|
|
|
|
K.Maeda,
D.Das,
P.D.Yin,
K.Tsuchiya,
H.Ogata-Aoki,
H.Nakata,
R.B.Norman,
L.A.Hackney,
Y.Takaoka,
and
H.Mitsuya
(2008).
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: insights into the mechanism of allosteric inhibition.
|
| |
J Mol Biol,
381,
956-974.
|
|
|
|
|
|
|
L.J.Miller
(2008).
G protein-coupled receptor structures, molecular associations, and modes of regulation.
|
| |
Ann N Y Acad Sci,
1144,
1-5.
|
|
|
|
|
|
|
L.J.Miller
(2008).
Informed development of drugs acting at family B G protein-coupled receptors.
|
| |
Ann N Y Acad Sci,
1144,
203-209.
|
|
|
|
|
|
|
L.Kaiser,
J.Graveland-Bikker,
D.Steuerwald,
M.Vanberghem,
K.Herlihy,
and
S.Zhang
(2008).
Efficient cell-free production of olfactory receptors: detergent optimization, structure, and ligand binding analyses.
|
| |
Proc Natl Acad Sci U S A,
105,
15726-15731.
|
|
|
|
|
|
|
L.M.Luttrell
(2008).
Reviews in molecular biology and biotechnology: transmembrane signaling by G protein-coupled receptors.
|
| |
Mol Biotechnol,
39,
239-264.
|
|
|
|
|
|
|
L.S.Cohen,
B.Arshava,
R.Estephan,
J.Englander,
H.Kim,
M.Hauser,
O.Zerbe,
M.Ceruso,
J.M.Becker,
and
F.Naider
(2008).
Expression and biophysical analysis of two double-transmembrane domain-containing fragments from a yeast G protein-coupled receptor.
|
| |
Biopolymers,
90,
117-130.
|
|
|
|
|
|
|
M.A.Hanson,
V.Cherezov,
M.T.Griffith,
C.B.Roth,
V.P.Jaakola,
E.Y.Chien,
J.Velasquez,
P.Kuhn,
and
R.C.Stevens
(2008).
A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor.
|
| |
Structure,
16,
897-905.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
M.Audet,
and
M.Bouvier
(2008).
Insights into signaling from the beta2-adrenergic receptor structure.
|
| |
Nat Chem Biol,
4,
397-403.
|
|
|
|
|
|
|
M.B.Dalrymple,
K.D.Pfleger,
and
K.A.Eidne
(2008).
G protein-coupled receptor dimers: functional consequences, disease states and drug targets.
|
| |
Pharmacol Ther,
118,
359-371.
|
|
|
|
|
|
|
M.C.Lagerström,
and
H.B.Schiöth
(2008).
Structural diversity of G protein-coupled receptors and significance for drug discovery.
|
| |
Nat Rev Drug Discov,
7,
339-357.
|
|
|
|
|
|
|
M.Foucaud,
E.Marco,
C.Escrieut,
C.Low,
B.Kalindjian,
and
D.Fourmy
(2008).
Linking Non-peptide Ligand Binding Mode to Activity at the Human Cholecystokinin-2 Receptor.
|
| |
J Biol Chem,
283,
35860-35868.
|
|
|
|
|
|
|
M.Hieke,
H.Zettl,
and
M.Schubert-Zsilavecz
(2008).
[GPCR--structure of the human beta-2 receptor clarified]
|
| |
Pharm Unserer Zeit,
37,
191-192.
|
|
|
|
|
|
|
M.J.Serrano-Vega,
F.Magnani,
Y.Shibata,
and
C.G.Tate
(2008).
Conformational thermostabilization of the {beta}1-adrenergic receptor in a detergent-resistant form.
|
| |
Proc Natl Acad Sci U S A,
105,
877-882.
|
|
|
|
|
|
|
M.M.Rosenkilde,
M.J.Smit,
and
M.Waldhoer
(2008).
Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors.
|
| |
Br J Pharmacol,
153,
S154-S166.
|
|
|
|
|
|
|
M.Mahalingam,
K.Martínez-Mayorga,
M.F.Brown,
and
R.Vogel
(2008).
Two protonation switches control rhodopsin activation in membranes.
|
| |
Proc Natl Acad Sci U S A,
105,
17795-17800.
|
|
|
|
|
|
|
M.Murakami,
and
T.Kouyama
(2008).
Crystal structure of squid rhodopsin.
|
| |
Nature,
453,
363-367.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
M.P.Bennett,
and
D.C.Mitchell
(2008).
Regulation of membrane proteins by dietary lipids: effects of cholesterol and docosahexaenoic acid acyl chain-containing phospholipids on rhodopsin stability and function.
|
| |
Biophys J,
95,
1206-1216.
|
|
|
|
|
|
|
N.P.Cowieson,
B.Kobe,
and
J.L.Martin
(2008).
United we stand: combining structural methods.
|
| |
Curr Opin Struct Biol,
18,
617-622.
|
|
|
|
|
|
|
P.Cozzini,
G.E.Kellogg,
F.Spyrakis,
D.J.Abraham,
G.Costantino,
A.Emerson,
F.Fanelli,
H.Gohlke,
L.A.Kuhn,
G.M.Morris,
M.Orozco,
T.A.Pertinhez,
M.Rizzi,
and
C.A.Sotriffer
(2008).
Target flexibility: an emerging consideration in drug discovery and design.
|
| |
J Med Chem,
51,
6237-6255.
|
|
|
|
|
|
|
P.M.Fischer
(2008).
Computational chemistry approaches to drug discovery in signal transduction.
|
| |
Biotechnol J,
3,
452-470.
|
|
|
|
|
|
|
P.S.Santos,
G.Füst,
Z.Prohászka,
A.Volz,
R.Horton,
M.Miretti,
C.Y.Yu,
S.Beck,
B.Uchanska-Ziegler,
and
A.Ziegler
(2008).
Association of smoking behavior with an odorant receptor allele telomeric to the human major histocompatibility complex.
|
| |
Genet Test,
12,
481-486.
|
|
|
|
|
|
|
R.J.Lefkowitz,
J.P.Sun,
and
A.K.Shukla
(2008).
A crystal clear view of the beta2-adrenergic receptor.
|
| |
Nat Biotechnol,
26,
189-191.
|
|
|
|
|
|
|
R.Sanishvili,
V.Nagarajan,
D.Yoder,
M.Becker,
S.Xu,
S.Corcoran,
D.L.Akey,
J.L.Smith,
and
R.F.Fischetti
(2008).
A 7 microm mini-beam improves diffraction data from small or imperfect crystals of macromolecules.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
425-435.
|
|
|
|
|
|
|
S.Costanzi
(2008).
On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor.
|
| |
J Med Chem,
51,
2907-2914.
|
|
|
|
|
|
|
S.Dove,
R.Seifert,
S.Elz,
and
A.Buschauer
(2008).
Frontiers in medicinal chemistry in Regensburg.
|
| |
ChemMedChem,
3,
1181-1184.
|
|
|
|
|
|
|
S.Monti,
I.Manet,
F.Manoli,
and
G.Marconi
(2008).
Structure and properties of licochalcone A-human serum albumin complexes in solution: a spectroscopic, photophysical and computational approach to understand drug-protein interaction.
|
| |
Phys Chem Chem Phys,
10,
6597-6606.
|
|
|
|
|
|
|
S.Mueller,
G.Kleinau,
H.Jaeschke,
R.Paschke,
and
G.Krause
(2008).
Extended hormone binding site of the human thyroid stimulating hormone receptor: distinctive acidic residues in the hinge region are involved in bovine thyroid stimulating hormone binding and receptor activation.
|
| |
J Biol Chem,
283,
18048-18055.
|
|
|
|
|
|
|
S.Newstead,
S.Ferrandon,
and
S.Iwata
(2008).
Rationalizing alpha-helical membrane protein crystallization.
|
| |
Protein Sci,
17,
466-472.
|
|
|
|
|
|
|
S.R.Ladwa,
S.J.Dilly,
A.J.Clark,
A.Marsh,
and
P.C.Taylor
(2008).
Rapid identification of a putative interaction between beta2-adrenoreceptor agonists and ATF4 using a chemical genomics approach.
|
| |
ChemMedChem,
3,
742-744.
|
|
|
|
|
|
|
S.R.McAllister,
and
C.A.Floudas
(2008).
Alpha-helical topology prediction and generation of distance restraints in membrane proteins.
|
| |
Biophys J,
95,
5281-5295.
|
|
|
|
|
|
|
S.Wu,
M.Birnbaumer,
and
Z.Guan
(2008).
Phosphorylation analysis of G protein-coupled receptor by mass spectrometry: identification of a phosphorylation site in V2 vasopressin receptor.
|
| |
Anal Chem,
80,
6034-6037.
|
|
|
|
|
|
|
S.Ye,
C.Köhrer,
T.Huber,
M.Kazmi,
P.Sachdev,
E.C.Yan,
A.Bhagat,
U.L.RajBhandary,
and
T.P.Sakmar
(2008).
Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesis.
|
| |
J Biol Chem,
283,
1525-1533.
|
|
|
|
|
|
|
T.Cens,
J.P.Leyris,
and
P.Charnet
(2008).
Introduction into Ca(v)2.1 of the homologous mutation of Ca(v)1.2 causing the Timothy syndrome questions the role of V421 in the phenotypic definition of P-type Ca(2+) channel.
|
| |
Pflugers Arch,
457,
417-430.
|
|
|
|
|
|
|
T.Huber,
and
T.P.Sakmar
(2008).
Rhodopsin's active state is frozen like a DEER in the headlights.
|
| |
Proc Natl Acad Sci U S A,
105,
7343-7344.
|
|
|
|
|
|
|
T.Shimamura,
K.Hiraki,
N.Takahashi,
T.Hori,
H.Ago,
K.Masuda,
K.Takio,
M.Ishiguro,
and
M.Miyano
(2008).
Crystal structure of squid rhodopsin with intracellularly extended cytoplasmic region.
|
| |
J Biol Chem,
283,
17753-17756.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
T.W.Schwartz,
and
W.L.Hubbell
(2008).
Structural biology: A moving story of receptors.
|
| |
Nature,
455,
473-474.
|
|
|
|
|
|
|
T.Warne,
M.J.Serrano-Vega,
J.G.Baker,
R.Moukhametzianov,
P.C.Edwards,
R.Henderson,
A.G.Leslie,
C.G.Tate,
and
G.F.Schertler
(2008).
Structure of a beta1-adrenergic G-protein-coupled receptor.
|
| |
Nature,
454,
486-491.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
T.Yamashita,
A.Terakita,
T.Kai,
and
Y.Shichida
(2008).
Conformational change of the transmembrane helices II and IV of metabotropic glutamate receptor involved in G protein activation.
|
| |
J Neurochem,
106,
850-859.
|
|
|
|
|
|
|
V.P.Jaakola,
M.T.Griffith,
M.A.Hanson,
V.Cherezov,
E.Y.Chien,
J.R.Lane,
A.P.Ijzerman,
and
R.C.Stevens
(2008).
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
|
| |
Science,
322,
1211-1217.
|
|
|
PDB code:
|
|
|
|
|
|
|
|
V.Subramaniam,
G.D.D'Ambruoso,
H.K.Hall,
R.J.Wysocki,
M.F.Brown,
and
S.S.Saavedra
(2008).
Reconstitution of rhodopsin into polymerizable planar supported lipid bilayers: influence of dienoyl monomer structure on photoactivation.
|
| |
Langmuir,
24,
11067-11075.
|
|
|
|
|
|
|
V.V.Gurevich,
and
E.V.Gurevich
(2008).
How and why do GPCRs dimerize?
|
| |
Trends Pharmacol Sci,
29,
234-240.
|
|
|
|
|
|
|
W.H.Frishman
(2008).
beta-Adrenergic blockers: a 50-year historical perspective.
|
| |
Am J Ther,
15,
565-576.
|
|
|
|
|
|
|
W.I.Weis,
and
B.K.Kobilka
(2008).
Structural insights into G-protein-coupled receptor activation.
|
| |
Curr Opin Struct Biol,
18,
734-740.
|
|
|
|
|
|
|
Y.Mo,
B.K.Lee,
J.F.Ankner,
J.M.Becker,
and
W.T.Heller
(2008).
Detergent-associated solution conformations of helical and beta-barrel membrane proteins.
|
| |
J Phys Chem B,
112,
13349-13354.
|
|
|
|
|
|
|
Y.X.Tao
(2008).
Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.
|
| |
Pharmacol Ther,
120,
129-148.
|
|
|
|
|
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
 |
|
Links
